Author: Sudarshana Datta, M.D.

Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants Are Associated With Similar Lower Risk of Coronary Heart Disease, Says a New Study
Cardiovascular Prevention, Coronary Artery Disease, News

Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants Are Associated With Similar Lower Risk of Coronary Heart Disease, Says a New Study

A study by Ference et al. published in JAMA showed that triglyceride-lowering LPL variants and LDL-C–lowering LDLR variants were associated with similar lower... Read more.
Randomized Trial Comparing Bilateral with Single Internal-Thoracic-Artery Grafting for CABG Shows No Significant Difference in All-Cause Mortality
Cardiovascular Surgery, Clinical Trials, News

Randomized Trial Comparing Bilateral with Single Internal-Thoracic-Artery Grafting for CABG Shows No Significant Difference in All-Cause Mortality

A recent study published in the New England Journal of Medicine showed that among patients who were scheduled for CABG and had been randomly assigned to undergo... Read more.
FFRCT Provides Superior Functional Assessment of Coronary Stenosis When Compared With Traditional Functional Imaging Techniques
Cardiovascular Imaging, News

FFRCT Provides Superior Functional Assessment of Coronary Stenosis When Compared With Traditional Functional Imaging Techniques

A study published in JACC reported that fractional flow reserve (FFR) computation from coronary computed tomography angiography (CTA) datasets (FFRCT) had higher... Read more.
FDA Issues Cautionary ‘Dear Doctor’ Letter In Response to Study Reporting Increased Deaths with Paclitaxel-Coated Devices in PAD
Interventional Cardiology, News, Prevention

FDA Issues Cautionary ‘Dear Doctor’ Letter In Response to Study Reporting Increased Deaths with Paclitaxel-Coated Devices in PAD

The FDA issued a Dear Doctor letter while investigating a potential safety signal with paclitaxel-coated balloons and stents used to treat peripheral artery disease.... Read more.